Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
24.08 USD | -0.21% | -.--% | +11.84% |
Nov. 20 | BNP Paribas Exane Lifts Price Target on Kenvue to $24 From $22 | MT |
Nov. 07 | Tranche Update on Kenvue Inc.'s Equity Buyback Plan announced on October 26, 2023. | CI |
MarketScreener Editorial Features
Sanofi : The Doliprane case | October 18, 2024 at 09:16 am EDT | |
Ten key beauty players | May 15, 2024 at 11:35 am EDT |
- Stock Market
- Equities
- KVUE Stock
- News Kenvue Inc.
- MarketScreener Editorial Features